Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

Public sector commitment to "open data" is patchy despite a raft of fine sounding policy statements. The "D" word…

The public sector market in the English north and midlands differs from that in the south and east. Suppliers…

The new procurement framework for Commissioning Support Units (CSUs) will not allay CCG concerns over commissioning…

With public sector austerity set to continue, governments across the world are looking to forge new relationships…

Neighbourhood planning, a measure brought in by the Localism Act to devolve power to local communities, may not…

Broadcast TV viewing is down 4% but only three percent of 16-24 yr olds give a damn, too busy risking obesity…

HealthCare Innovation Daily (an Information Daily channel) is supporting Science Capital in presenting their Innovative…

VIDEO: At June’s Making a Difference with Data event, Barnet Chief Operating Officer Chris Naylor spoke…

Do you do digital? Take the test

The Information Daily is collaborating with Socitm to research organisations' commitment to and capability for a digital future.

Take the test

View Results

If you have already taken the test, you may view the latest detailed results by entering your email address below


Headline results so far: Results from 104 users

Corporate commitment: 48%
0%
100%
50%
Digital capability: 54%
0%
100%
50%

MPs and campaigners want suppliers to be covered by Freedom of Information law, with the Cabinet Office considering…

"Most media outlets," including some stellar Fleet Street titles, have been ticked off by NHS Choices for getting…

Good, collaborative relationships and whole system sign up are key to effective health and care integration, improved…

VIDEO: Capita Analytics Director Neil Mackin talking about the importance of open data and using data in the local…